Submitted by Anonymous (not verified) on 16 September 2024 - 12:20
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 60, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 60, Status: Authorised